Over The Counter Drugs Market by Product (Analgesics, Cough, Cold, & Flu Products, Dermatology Products), Distribution Channel (Hospital Pharmacies, Online Stores, Retail Pharmacies) - Global Forecast 2024-2030

Over The Counter Drugs Market by Product (Analgesics, Cough, Cold, & Flu Products, Dermatology Products), Distribution Channel (Hospital Pharmacies, Online Stores, Retail Pharmacies) - Global Forecast 2024-2030


The Over The Counter Drugs Market size was estimated at USD 464.14 billion in 2023 and expected to reach USD 504.86 billion in 2024, at a CAGR 8.86% to reach USD 841.20 billion by 2030.

Global Over The Counter Drugs Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Over The Counter Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Over The Counter Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Over The Counter Drugs Market, highlighting leading vendors and their innovative profiles. These include Alembic Pharmaceuticals Ltd., Alkem Laboratories Limited, Cipla, Inc., Dr. Reddy's Laboratories, Glaxosmithkline PLC, Glenmark Pharmaceuticals Limited, Hetero Drugs Ltd., Johnson & Johnson Pvt. Ltd., Lupin Limited, Mankind Pharma, Mylan Pharmaceuticals Pvt. Ltd. by Viatris, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Over The Counter Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Analgesics
Cough, Cold, & Flu Products
Dermatology Products
Gastrointestinal Products
Ophthalmic Products
Sleeping Aids
Vitamins, Mineral, & Supplements
Weight-Loss & Dietary Products
Distribution Channel
Hospital Pharmacies
Online Stores
Retail Pharmacies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Over The Counter Drugs Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Over The Counter Drugs Market?
3. What are the technology trends and regulatory frameworks in the Over The Counter Drugs Market?
4. What is the market share of the leading vendors in the Over The Counter Drugs Market?
5. Which modes and strategic moves are suitable for entering the Over The Counter Drugs Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Over The Counter Drugs Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Cost effective way to treat minor health issues
5.1.1.2. Reduced burden of the physician
5.1.1.3. Favorable regulatory framework
5.1.2. Restraints
5.1.2.1. Presence of substitute drug due to saturating market
5.1.3. Opportunities
5.1.3.1. Increased accessibility through retail outlets and supermarkets
5.1.3.2. Technological advancement and product innovation
5.1.4. Challenges
5.1.4.1. Pressure to keep the price low
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Over The Counter Drugs Market, by Product
6.1. Introduction
6.2. Analgesics
6.3. Cough, Cold, & Flu Products
6.4. Dermatology Products
6.5. Gastrointestinal Products
6.6. Ophthalmic Products
6.7. Sleeping Aids
6.8. Vitamins, Mineral, & Supplements
6.9. Weight-Loss & Dietary Products
7. Over The Counter Drugs Market, by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Stores
7.4. Retail Pharmacies
8. Americas Over The Counter Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Over The Counter Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Over The Counter Drugs Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Alembic Pharmaceuticals Ltd.
12.1.2. Alkem Laboratories Limited
12.1.3. Cipla, Inc.
12.1.4. Dr. Reddy's Laboratories
12.1.5. Glaxosmithkline PLC
12.1.6. Glenmark Pharmaceuticals Limited
12.1.7. Hetero Drugs Ltd.
12.1.8. Johnson & Johnson Pvt. Ltd.
12.1.9. Lupin Limited
12.1.10. Mankind Pharma
12.1.11. Mylan Pharmaceuticals Pvt. Ltd. by Viatris
12.1.12. Pfizer Inc.
12.1.13. Sanofi S.A.
12.1.14. Sun Pharmaceutical Industries Ltd.
12.1.15. Teva Pharmaceutical Industries Ltd.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. OVER THE COUNTER DRUGS MARKET RESEARCH PROCESS
FIGURE 2. OVER THE COUNTER DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. OVER THE COUNTER DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. OVER THE COUNTER DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. OVER THE COUNTER DRUGS MARKET DYNAMICS
FIGURE 7. OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 10. OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. OVER THE COUNTER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. OVER THE COUNTER DRUGS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings